Download PDF
Semin Thromb Hemost 2006; 32(2): 105-112
DOI: 10.1055/s-2006-939766
Copyright © 2006 by Thieme Medical Publishers, Inc., 333 Seventh Avenue, New York, NY 10001, USA.

New Aspects in the Pathogenesis of Enteropathic Hemolytic Uremic Syndrome

Helge Karch1 , Alexander W. Friedrich1 , Angela Gerber2 , Lothar B. Zimmerhackl3 , M. Alexander Schmidt4 , Martina Bielaszewska1
  • 1Institut für Hygiene und Konsiliarlaboratorium für Hämolytisch-Urämisches Syndrom, Universitätsklinikum Münster, Münster, Germany
  • 2Zentrum für Kinderheilkunde und Jugendmedizin, Universität Freiburg, Freiburg, Germany
  • 3Universitätsklinik für Kinder- und Jugendmedizin, Universität Innsbruck, Innsbruck, Austria
  • 4Institut für Infektiologie, Zentrum für Molekularbiologie der Entzündung, Universitätsklinikum Münster, Münster, Germany
Further Information

Publication History

Publication Date:
30 March 2006 (online)

    Permissions and Reprints

ABSTRACT

Shiga toxin (Stx) subtyping suggests that the clinical outcome of infections caused by Shiga toxin-producing Escherichia coli (STEC) depends, in large part, on the stx genotype of the infecting strain. Whereas the presence of the stx2 or stx2c genotype is associated with the ability of STEC to cause the hemolytic uremic syndrome (HUS), strains possessing stx2d or stx2e have been isolated from patients with less severe disease. In addition to the type of Stx, the level of Stx production might be critical for the pathogenicity of STEC. Control of Stx expression appears to be at the level of transcription. Injury to microvascular endothelial cells is the key event underlying the pathogenesis of HUS. We could show that in addition to Stx, STEC also produces other putative virulence factors, such as cytolethal distending toxin, which can contribute to the endothelial injury by interference with the cell cycle, which results in inhibition of cell proliferation and finally cell death.

KEYWORDS

Hemolytic uremic syndrome (HUS) - pathogenesis of HUS - Shiga toxin - children - endothelial cells - endothelial damage

REFERENCES

  • 1 Karmali M A. Infection by Shiga toxin-producing Escherichia coli: an overview.  Mol Biotechnol. 2004;  26 117-122
    CrossrefPubMedGoogle Scholar
  • 2 Tarr P I, Gordon C A, Chandler W L. Shiga toxin-producing Escherichia coli and the haemolytic uraemic syndrome.  Lancet. 2005;  365 1073-1086
    PubMedGoogle Scholar
  • 3 Caprioli A, Morabito S, Brugereb H et al.. Enterohaemorrhagic Escherichia coli: emerging issues on virulence and modes of transmission.  Vet Res. 2005;  36 289-311
    CrossrefPubMedGoogle Scholar
  • 4 Scotland S M, Smith H R, Rowe B. Two distinct toxins active on Vero cells from Escherichia coli O157:H7.  Lancet. 1985;  2 885-886
    PubMedGoogle Scholar
  • 5 O'Brien A D, Tesh V L, Donohue-Rolfe A et al.. Shiga toxin: biochemistry, genetics, mode of action, and role in pathogenesis.  Curr Top Microbiol Immunol. 1992;  180 65-94
    PubMedGoogle Scholar
  • 6 Sandvig K. Shiga toxins.  Toxicon. 2001;  39 1629-1635
    CrossrefPubMedGoogle Scholar
  • 7 Zhang W, Bielaszewska M, Kuczius T et al.. Identification, characterization and distribution of a Shiga toxin 1 gene variant (stx1c ) in Escherichia coli isolated from humans.  J Clin Microbiol. 2002;  40 1441-1446
    CrossrefPubMedGoogle Scholar
  • 8 Friedrich A W, Borell J, Bielaszewska M et al.. Shiga toxin 1c-producing Escherichia coli strains: phenotypic and genetic characterization and association with human disease.  J Clin Microbiol. 2003;  41 2448-2453
    CrossrefPubMedGoogle Scholar
  • 9 Bürk C, Dietrich R, Acar G et al.. Identification and characterization of a new variant of Shiga toxin 1 in Escherichia coli ONT:H19 of bovine origin.  J Clin Microbiol. 2003;  41 2106-2112
    CrossrefPubMedGoogle Scholar
  • 10 Kuczius T, Bielaszewska M, Friedrich A W et al.. A rapid method for the discrimination of genes encoding classical Shiga toxin (Stx) 1 and its variants, Stx1c and Stx1d, in Escherichia coli. .  Mol Nutr Food Res. 2004;  48 515-521
    CrossrefPubMedGoogle Scholar
  • 11 Schmitt C K, McKee M L, O'Brien A D. Two copies of shiga-like toxin II-related genes common in enterohemorrhagic Escherichia coli strains are responsible for the antigenic heterogeneity of the O157:H- strain E32511.  Infect Immun. 1991;  59 1065-1073
    PubMedGoogle Scholar
  • 12 Jelacic J K, Damrow T, Chen G S et al.. Shiga toxin-producing Escherichia coli in Montana: bacterial genotypes and clinical profiles.  J Infect Dis. 2003;  188 719-729
    CrossrefPubMedGoogle Scholar
  • 13 Melton-Celsa A R, Darnell S C, O'Brien A D. Activation of Shiga-like toxins by mouse and human intestinal mucus correlates with virulence of enterohemorrhagic Escherichia coli O91:H21 isolates in orally infected, streptomycin-treated mice.  Infect Immun. 1996;  64 1569-1576
    PubMedGoogle Scholar
  • 14 Pierard D, Muyldermas G, Moriau L et al.. Identification of new Verocytotoxin type 2 variant B-subunit genes in human and animal Escherichia coli isolates.  J Clin Microbiol. 1998;  36 3317-3322
    PubMedGoogle Scholar
  • 15 Sonntag A K, Bielaszewska M, Mellmann A et al.. Shiga toxin 2e-producing Escherichia coli from humans and pigs differ by their virulence profiles and interaction with intestinal epithelial cells.  Appl Environ Microbiol. 2005;  71 8855-8863
    CrossrefPubMedGoogle Scholar
  • 16 Schmidt H, Scheef J, Morabito S et al.. A new Shiga toxin 2 variant (Stx2f) from Escherichia coli isolated from pigeons.  Appl Environ Microbiol. 2000;  66 1205-1208
    CrossrefPubMedGoogle Scholar
  • 17 Sonntag A-K, Zenner E, Karch H et al.. Pigeons as a possible reservoir of Shiga toxin 2f-producing Escherichia coli pathogenic to humans.  Berl Munch Tierarztl Wochenschr. 2005;  118 464-470
    PubMedGoogle Scholar
  • 18 Beutin L, Krause G, Zimmermann S et al.. Characterization of Shiga toxin-producing Escherichia coli strains isolated from human patients in Germany over a 3-year period.  J Clin Microbiol. 2004;  42 1099-1108
    CrossrefPubMedGoogle Scholar
  • 19 Staschen B, Friedrich A W, Schröder M et al.. Incidence of enterohemorrhagic Escherichia coli (EHEC) in hospitalized children with diarrhea in northern Germany.  Monatsschrift Kinderheilkunde. 2004;  152 1077-1083
    CrossrefPubMedGoogle Scholar
  • 20 Kehl K S, Havens P, Behnke C E et al.. Evaluation of the premier EHEC assay for detection of Shiga toxin-producing Escherichia coli .  J Clin Microbiol. 1997;  35 2051-2054
    PubMedGoogle Scholar
  • 21 Karmali M A, Petric M, Bielaszewska M. Evaluation of a microplate latex agglutination method (Verotox-F) for detecting and characterizing verotoxins (Shiga toxins) in Escherichia coli .  J Clin Microbiol. 1999;  37 396-399
    PubMedGoogle Scholar
  • 22 Zhang W, Bielaszewska M, Friedrich A W et al.. Transcriptional analysis of genes encoding Shiga toxin 2 and its variants in Escherichia coli. .  Appl Environ Microbiol. 2005;  71 558-561
    CrossrefPubMedGoogle Scholar
  • 23 Friedrich A W, Bielaszewska M, Zhang W L et al.. Escherichia coli harboring Shiga toxin 2 gene variants: frequency and association with clinical symptoms.  J Infect Dis. 2002;  185 74-84
    CrossrefPubMedGoogle Scholar
  • 24 Kusumoto M, Nishiya Y, Kawamura Y et al.. Identification of an insertion sequence, IS1203 variant, in a Shiga toxin 2 gene of Escherichia coli O145:H7.  J Biosci Bioeng. 1999;  87 93-96
    CrossrefPubMedGoogle Scholar
  • 25 Reischl U, Youssef M T, Kilwinski J et al.. Real-time fluorescence PCR assays for detection and characterization of Shiga toxin, intimin, and enterohemolysin genes from Shiga toxin-producing Escherichia coli. .  J Clin Microbiol. 2002;  40 2555-2565
    CrossrefPubMedGoogle Scholar
  • 26 Pulz M, Matussek A, Monazahian M et al.. Comparison of a Shiga toxin enzyme-linked immunosorbent assay and two types of PCR for detection of shiga toxin-producing Escherichia coli in human stool specimens.  J Clin Microbiol. 2003;  41 4671-4675
    CrossrefPubMedGoogle Scholar
  • 27 Mellmann A, Bielaszewska M, Zimmerhackl L B et al.. Enterohemorrhagic Escherichia coli in human infection: in vivo evolution of a bacterial pathogen.  Clin Infect Dis. 2005;  41 785-792
    CrossrefPubMedGoogle Scholar
  • 28 Janka A, Bielaszewska M, Dobrindt U et al.. Identification and distribution of the enterohemorrhagic Escherichia coli factor for adherence (efa1) gene in sorbitol-fermenting Escherichia coli O157:H- .  Int J Med Microbiol. 2002;  292 207-214
    CrossrefPubMedGoogle Scholar
  • 29 Janka A, Bielaszewska M, Dobrindt U et al.. The cytolethal distending toxin (cdt) gene cluster in enterohemorrhagic Escherichia coli O157:H- and O157:H7: characterization and evolutionary considerations.  Infect Immun. 2003;  71 3634-3638
    CrossrefPubMedGoogle Scholar
  • 30 Janka A, Becker G, Sonntag A-K et al.. Presence and characterization of a mosaic genomic island which distinguishes sorbitol-fermenting enterohemorrhagic Escherichia coli O157:H- from E. coli O157:H7.  Appl Environ Microbiol. 2005;  71 4875-4878
    CrossrefPubMedGoogle Scholar
  • 31 Dobrindt U, Agerer F, Michaelis K et al.. Analysis of genome plasticity in pathogenic and commensal Escherichia coli isolates by use of DNA arrays.  J Bacteriol. 2003;  185 1831-1840
    CrossrefPubMedGoogle Scholar
  • 32 Oswald E, Schmidt H, Morabito S et al.. Typing of intimin genes in human and animal enterohemorrhagic and enteropathogenic Escherichia coli: characterization of a new intimin variant.  Infect Immun. 2000;  68 64-71
    CrossrefPubMedGoogle Scholar
  • 33 Zhang W-L, Köhler B, Oswald E et al.. Genetic diversity of intimin genes of attaching and effacing Escherichia coli strains.  J Clin Microbiol. 2002;  40 4486-4492
    CrossrefPubMedGoogle Scholar
  • 34 Nataro J P, Kaper J B. Diarrheagenic Escherichia coli. .  Clin Microbiol Rev. 1998;  11 142-201
    PubMedGoogle Scholar
  • 35 Tarr P I, Bilge S S, Vary J C et al.. Iha: a novel Escherichia coli O157:H7 adherence-conferring molecule encoded on a recently acquired chromosomal island of conserved structure.  Infect Immun. 2000;  68 1400-1407
    CrossrefPubMedGoogle Scholar
  • 36 Nicholls L, Grant T H, Robins-Browne R M. Identification of a novel genetic locus that is required for in vitro adhesion of a clinical isolate of enterohaemorrhagic Escherichia coli to epithelial cells.  Mol Microbiol. 2000;  35 275-288
    CrossrefPubMedGoogle Scholar
  • 37 Paton A W, Srimanote P, Woodrow M C et al.. Characterization of Saa, a novel autoagglutinating adhesin produced by locus of enterocyte effacement-negative Shiga-toxigenic Escherichia coli strains that are virulent for humans.  Infect Immun. 2001;  69 6999-7009
    CrossrefPubMedGoogle Scholar
  • 38 Friedrich A W, Nierhoff K V, Bielaszewska M et al.. Phylogeny, clinical associations, and diagnostic utility of the pilin subunit gene (sfpA) of sorbitol-fermenting, enterohemorrhagic Escherichia coli O157:H- .  J Clin Microbiol. 2004;  42 4697-4701
    CrossrefPubMedGoogle Scholar
  • 39 Doughty S, Sloan J, Bennett-Wood V et al.. Identification of a novel fimbrial gene cluster related to long polar fimbriae in locus of enterocyte effacement-negative strains of enterohemorrhagic Escherichia coli. .  Infect Immun. 2002;  70 6761-6769
    CrossrefPubMedGoogle Scholar
  • 40 Karmali M A, Mascarenhas M, Shen S et al.. Association of genomic O island 122 of Escherichia coli EDL 933 with verocytotoxin-producing Escherichia coli seropathotypes that are linked to epidemic and/or serious disease.  J Clin Microbiol. 2003;  41 4930-4940
    CrossrefPubMedGoogle Scholar
  • 41 Jores J, Wagner S, Rumer L et al.. Description of a 111-kb pathogenicity island (PAI) encoding various virulence features in the enterohemorrhagic E. coli (EHEC) strain RW1374 (O103:H2) and detection of a similar PAI in other EHEC strains of serotype 0103:H2.  Int J Med Microbiol. 2005;  294 417-425
    CrossrefPubMedGoogle Scholar
  • 42 Lathem W W, Grys T E, Witowski S E et al.. StcE, a metalloprotease secreted by Escherichia coli O157:H7, specifically cleaves C1 esterase inhibitor.  Mol Microbiol. 2002;  45 277-288
    CrossrefPubMedGoogle Scholar
  • 43 Paton A W, Srimanote P, Talbot U M et al.. A new family of potent AB5 cytotoxins produced by Shiga toxigenic Escherichia coli. .  J Exp Med. 2004;  200 35-46
    CrossrefPubMedGoogle Scholar
  • 44 Bielaszewska M, Fell M, Greune L et al.. Characterization of cytolethal distending toxin genes and expression in Shiga toxin-producing Escherichia coli strains of non-O157 serogroups.  Infect Immun. 2004;  72 1812-1816
    CrossrefPubMedGoogle Scholar
  • 45 Bielaszewska M, Sinha B, Kuczius T et al.. Cytolethal distending toxin from Shiga toxin-producing Escherichia coli O157 causes irreversible G2/M arrest, inhibition of proliferation and death of human endothelial cells.  Infect Immun. 2005;  73 552-562
    CrossrefPubMedGoogle Scholar
  • 46 Bielaszewska M, Zhang W, Tarr P I et al.. Molecular profiling and phenotype analysis of Escherichia coli O26:H11 and O26:NM: secular and geographic consistency of enterohemorrhagic and enteropathogenic isolates.  J Clin Microbiol. 2005;  43 4225-4228
    CrossrefPubMedGoogle Scholar
  • 47 Bielaszewska M, Tarr P I, Karch H et al.. Phenotypic and molecular analysis of tellurite resistance among enterohemorrhagic Escherichia coli O157:H7 and sorbitol-fermenting O157:NM clinical isolates.  J Clin Microbiol. 2005;  43 452-454
    CrossrefPubMedGoogle Scholar
  • 48 Friedrich A W, Köck R, Bielaszewska M et al.. Distribution of the urease gene cluster among and urease activities of enterohemorrhagic Escherichia coli O157 isolates from humans.  J Clin Microbiol. 2005;  43 546-550
    CrossrefPubMedGoogle Scholar
  • 49 Thelestam M, Frisan T. Cytolethal distending toxins.  Rev Physiol Biochem Pharmacol. 2004;  152 111-133
    CrossrefPubMedGoogle Scholar
  • 50 Cortes-Bratti X, Frisan T, Thelestam M. The cytolethal distending toxins induce DNA damage and cell cycle arrest.  Toxicon. 2001;  39 1729-1736
    CrossrefPubMedGoogle Scholar
  • 51 Scott D A, Kaper J B. Cloning and sequencing of the genes encoding Escherichia coli cytolethal distending toxin.  Infect Immun. 1994;  62 244-251
    PubMedGoogle Scholar
  • 52 Pickett C L, Cottle D L, Pesci E C et al.. Cloning, sequencing, and expression of the Escherichia coli cytolethal distending toxin genes.  Infect Immun. 1994;  62 1046-1051
    PubMedGoogle Scholar
  • 53 Peres S Y, Marches O, Daigle F et al.. A new cytolethal distending toxin (CDT) from Escherichia coli producing CNF2 blocks HeLa cell division in G2/M phase.  Mol Microbiol. 1997;  24 1095-1107
    CrossrefPubMedGoogle Scholar
  • 54 Elwell C A, Dreyfus L A. DNase I homologous residues in CdtB are critical for cytolethal distending toxin-mediated cell cycle arrest.  Mol Microbiol. 2000;  37 952-963
    CrossrefPubMedGoogle Scholar
  • 55 Lara-Tejero M, Galan J E. A bacterial toxin that controls cell cycle progression as a deoxyribonuclease I-like protein.  Science. 2000;  290 354-357
    CrossrefPubMedGoogle Scholar
  • 56 Lara-Tejero M, Galan J E. CdtA, CdtB, and CdtC form a tripartite complex that is required for cytolethal distending toxin activity.  Infect Immun. 2001;  69 4358-4365
    CrossrefPubMedGoogle Scholar
  • 57 Deng K, Hansen E JA. CdtA-CdtC complex can block killing of HeLa cells by Haemophilus ducreyi cytolethal distending toxin.  Infect Immun. 2003;  71 6633-6640
    CrossrefPubMedGoogle Scholar
  • 58 Toth I, Herault F, Beutin L et al.. Production of cytolethal distending toxins by pathogenic Escherichia coli isolated from human and animal sources: Establishment of the existence of a new cdt variant (type IV).  J Clin Microbiol. 2003;  41 4285-4291
    CrossrefPubMedGoogle Scholar
  • 59 Prager R, Annemuller S, Tschäpe H. Diversity of virulence patterns among shiga toxin-producing Escherichia coli from human clinical cases-need for more detailed diagnostics.  Int J Med Microbiol. 2005;  295 29-38
    CrossrefPubMedGoogle Scholar
  • 60 Pickett C L, Lee R B, Eyigor A et al.. Patterns of variations in Escherichia coli strains that produce cytolethal distending toxin.  Infect Immun. 2004;  72 684-690
    CrossrefPubMedGoogle Scholar
  • 61 Richardson S E, Karmali M A, Becker L E et al.. The histopathology of the hemolytic uremic syndrome associated with verocytotoxin-producing Escherichia coli infections.  Hum Pathol. 1988;  19 1102-1108
    CrossrefPubMedGoogle Scholar
  • 62 Matussek A, Lauber J, Bergau A et al.. Molecular and functional analysis of Shiga toxin-induced response patterns in human vascular endothelial cells.  Blood. 2003;  102 1323-1332
    CrossrefPubMedGoogle Scholar
  • 63 Gerber A, Karch H, Allerberger F et al.. Clinical course and the role of Shiga toxin-producing Escherichia coli infection in the hemolytic-uremic syndrome in pediatric patients, 1997-2000, in Germany and Austria: a prospective study.  J Infect Dis. 2002;  186 493-500
    CrossrefPubMedGoogle Scholar
  • 64 Sonntag A, Prager R, Bielaszewska M et al.. Phenotypic and genotypic analyses of enterohemorrhagic Escherichia coli O145 strains from patients in Germany.  J Clin Microbiol. 2004;  42 954-962
    CrossrefPubMedGoogle Scholar
  • 65 Misselwitz J, Karch H, Bielazewska M et al.. Cluster of hemolytic-uremic syndrome caused by Shiga toxin-producing Escherichia coli O26:H11.  J Pediatr Infect Dis J. 2003;  22 349-354
    PubMedGoogle Scholar

Helge KarchPh.D. 

Professor, Institut für Hygiene, Universitätsklinikum Münster

Robert-Koch-Str. 41, D-48149 Münster, Germany

Email: hkarch@uni-muenster.de

      >